Coloplast Buys Fish-Skin Tissue Graft Maker for $1.3 Billion (2)

Coloplast A/S is acquiring Kerecis hf, a closely held Icelandic maker of fish-skin dressings to treat human wounds, for an enterprise value of up to $1.3 billion.

Coloplast is making a $1.2 billion cash payment upfront and expects earnout potential of a maximum of $100 million, according to a statement Friday. The transaction is expected to be financed through an equity capital raise.

As a result of the acquisition, Coloplast raised its long-term organic growth guidance to 8-10%, from a previous 7-9%, with the transaction seen as increasingly accretive to earnings per share from its 2026/27 fiscal year.

Coloplast A/S headquarters in Humlebaek, Denmark.

Source: Coloplast A/S

The ...